| M. de los Frailes |
9:00 |
Medium Content- High Throughput” Screening Technologies: Halfway between in vitro assays and High Content Analysis techniques |
M. de los Frailes, GSK, Tres Cantos, Spain |
| M. de los Frailes |
9:30 |
Cutting Edge Tools for Cellular Analysis in Imaging, Qdot™, Nanocrystals, Alexa Fluor™ & Pacific™, Dyes, Zenon™ |
T. Bauer, Molecular Probes |
| M. de los Frailes |
10:00 |
Open High Content Screening platform for large scale projects. Experiences, developments and assays including genome wide 48h live cell array imaging |
U. Liebel, KIT, Karlsruhe, Germany |
| M. de los Frailes |
10:30 |
Genome-scale HT-RNAi screen using high content assay in HUVECs for novel anti-angiogenic drug targets |
C. Weiss, Cenix BioScience, Dresden, Germany |
| |
11:00 |
Coffee Break and Exhibition |
| U. Liebel |
11:30 |
Expression Arrest™Lentiviral shRNAmir . . . Versatile RNAi Tools advance Genome-Wide Screening and Animal Model Development |
G. Fewell, Openbiosystem, Huntsville, USA |
| U. Liebel |
12:00 |
Title to be confirmed |
M. Brown, Bioimage Copenhagen, DK |
| U. Liebel |
12:30 |
Technological Advantages of the 27-mer Dicer-substrate siRNAs in RNAi research |
J. Alba, Biorad |
| |
13:00 |
Lunch and Exhibition |
| R. L. Beijersbergen |
14:30 |
High-Content RNAi Screening for Genome-Wide Functional Analysis to Identify Novel Regulators of Endocytic Pathways |
M. Stöter, MPI, Dresden, Germany |
| R. L. Beijersbergen |
15:00 |
RNAi and HCS: Getting High on Content |
R. L. Beijersbergen, NKI, Amsterdam, Netherlands |
| R. L. Beijersbergen |
15:30 |
Loss of Function Screening Using a Lentiviral RNAi Library to Identify Genes that Modulate Cellular Response to Paclitaxel |
H. J. George, Sigma-Aldrich Company, St. Louis, USA |
| |
16:00 |
Coffee & Poster Viewing (CNIC) |
| |
16:30 |
Practical session #2 (CNIC) |
| |
|
Open end |